Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Non-Current Assets (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Non-Current Assets data on record, last reported at $993.5 million in Q3 2025.

  • For Q3 2025, Non-Current Assets fell 16.61% year-over-year to $993.5 million; the TTM value through Sep 2025 reached $4.3 billion, up 48.26%, while the annual FY2024 figure was $1.2 billion, 95.03% up from the prior year.
  • Non-Current Assets reached $993.5 million in Q3 2025 per COLL's latest filing, down from $1.0 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.2 billion in Q3 2024 and bottomed at $349.8 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $738.9 million, with a median of $716.0 million recorded in 2023.
  • Peak YoY movement for Non-Current Assets: soared 152.32% in 2022, then dropped 19.72% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $376.5 million in 2021, then surged by 100.29% to $754.1 million in 2022, then dropped by 19.68% to $605.7 million in 2023, then surged by 95.03% to $1.2 billion in 2024, then dropped by 15.9% to $993.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $993.5 million in Q3 2025, $1.0 billion in Q2 2025, and $1.1 billion in Q1 2025.